Enhancement of cisplatin sensitivity in human breast cancer MCF-7 cell line through BiP and 14-3-3ζ co-knockdown
- Authors:
- Tahereh Kashkoulinejad-Kouhi
- Shahrokh Safarian
- Blanca Arnaiz
- Laura Saa
-
Affiliations: Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran 1417614411, Iran, Carbon Bionanotechnology Group, CIC biomaGUNE, 20014 San Sebastian, Spain, Biosensing Group, CIC biomaGUNE, 20014 San Sebastian, Spain - Published online on: December 14, 2020 https://doi.org/10.3892/or.2020.7898
- Pages: 665-679
-
Copyright: © Kashkoulinejad-Kouhi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Torre LA, Islami F, Siegel RL, Ward EM and Jemal A: Global cancer in women: Burden and trends. Cancer Epidemiol Biomarkers Prev. 26:444–457. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wu G, Zhou W, Pan X, Sun Y, Xu H, Shi P, Li J, Gao L and Tian X: miR-100 reverses cisplatin resistance in breast cancer by suppressing HAX-1. Cell Physiol Biochem. 47:2077–2087. 2018. View Article : Google Scholar : PubMed/NCBI | |
Cook KL, Clarke PA, Parmar J, Hu R, Schwartz-Roberts JL, Abu-Asab M, Wärri A, Baumann WT and Clarke R: Knockdown of estrogen receptor-α induces autophagy and inhibits antiestrogen-mediated unfolded protein response activation, promoting ROS-induced breast cancer cell death. FASEB J. 28:3891–3905. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hu R, Warri A, Jin L, Zwart A, Riggins RB, Fang HB and Clarke R: NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer. Mol Cell Biol. 35:379–390. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yeung BH, Kwan BW, He QY, Lee AS, Liu J and Wong AS: Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis. Oncogene. 27:6782–6789. 2008. View Article : Google Scholar : PubMed/NCBI | |
Zhang X, Cook KL, Warri A, Cruz IM, Rosim M, Riskin J, Helferich W, Doerge D, Clarke R and Hilakivi-Clarke L: Lifetime genistein intake increases the response of mammary tumors to tamoxifen in rats. Clin Cancer Res. 23:814–824. 2017. View Article : Google Scholar : PubMed/NCBI | |
Christowitz C, Davis T, Isaacs A, van Niekerk G, Hattingh S and Engelbrecht AM: Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer. 19:7572019. View Article : Google Scholar : PubMed/NCBI | |
Ma W, Teng Y, Hua H, Hou J, Luo T and Jiang Y: Upregulation of heat shock protein 27 confers resistance to actinomycin D-induced apoptosis in cancer cells. FEBS J. 280:4612–4624. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wang Q, Cui K, Espin-Garcia O, Cheng D, Qiu X, Chen Z, Moore M, Bristow RG, Xu W, Der S, et al: Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis. PLoS One. 8:e823632013. View Article : Google Scholar : PubMed/NCBI | |
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kaufman RJ: Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev. 13:1211–1233. 1999. View Article : Google Scholar : PubMed/NCBI | |
Luo B and Lee AS: The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene. 32:805–818. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kosakowska-Cholody T, Lin J, Srideshikan SM, Scheffer L, Tarasova NI and Acharya JK: HKH40A downregulates GRP78-BiP expression in cancer cells. Cell Death Dis. 5:e12402014. View Article : Google Scholar : PubMed/NCBI | |
Avril T, Vauléon E and Chevet E: Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis. 6:e3732017. View Article : Google Scholar : PubMed/NCBI | |
Lee E, Nichols P, Spicer D, Groshen S, Yu MC and Lee AS: GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res. 66:7849–7853. 2006. View Article : Google Scholar : PubMed/NCBI | |
Andruska N, Zheng X, Yang X, Helferich WG and Shapiro DJ: Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer. Oncogene. 34:3760–3769. 2015. View Article : Google Scholar : PubMed/NCBI | |
Davies MPA, Barraclough DL, Stewart C, Joyce KA, Eccles RM, Barraclough R, Rudland PS and Sibson DR: Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer. Int J Cancer. 123:85–88. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lee E, Nichols P, Groshen S, Spicer D and Lee AS: GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy. Int J Cancer. 128:726–731. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gottesman MM: Mechanisms of cancer drug resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI | |
Holohan C, Van Schaeybroeck S, Longley DB and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat Rev Cancer. 13:714–726. 2013. View Article : Google Scholar : PubMed/NCBI | |
Longley DB and Johnston PG: Molecular mechanisms of drug resistance. J Pathol. 205:275–292. 2005. View Article : Google Scholar : PubMed/NCBI | |
Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN, Schwartz AM, Kennedy KA and Patierno SR: Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat. 59:15–26. 2000. View Article : Google Scholar : PubMed/NCBI | |
Pyrko P, Schönthal AH, Hofman FM, Chen TC and Lee AS: The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res. 67:9809–9816. 2007. View Article : Google Scholar : PubMed/NCBI | |
Lee HK, Xiang C, Cazacu S, Finniss S, Kazimirsky G, Lemke N, Lehman NL, Rempel SA, Mikkelsen T and Brodie C: GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. Neuro Oncol. 10:236–243. 2008. View Article : Google Scholar : PubMed/NCBI | |
Epple LM, Dodd RD, Merz AL, Dechkovskaia AM, Herring M, Winston BA, Lencioni AM, Russell RL, Madsen H, Nega M, et al: Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells. PLoS One. 8:e732672013. View Article : Google Scholar : PubMed/NCBI | |
Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H and Haga N: Molecular targeting therapy of cancer: Drug resistance, apoptosis and survival signal. Cancer Sci. 94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI | |
Salazar M, Hernández-Tiedra S, Torres S, Lorente M, Guzmán M and Velasco G: Detecting autophagy in response to ER stress signals in cancer. Methods Enzymol. 489:297–317. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sokolowska I, Woods AG, Gawinowicz MA, Roy U and Darie CC: Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells. J Biol Chem. 287:1719–1733. 2012. View Article : Google Scholar : PubMed/NCBI | |
Baptista MZ, Sarian LO, Vassallo J, Pinto GA, Soares FA and de Souza GA: Prognostic significance of GRP78 expression patterns in breast cancer patients receiving adjuvant chemotherapy. Int J Biol Markers. 26:188–196. 2011. View Article : Google Scholar : PubMed/NCBI | |
La X, Zhang L, Li H, Li Z, Song G, Yang P and Yang Y: Ajuba receptor mediates the internalization of tumor-secreted GRP78 into macrophages through different endocytosis pathways. Oncotarget. 9:15464–15479. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Wang JH, Zhang XL, Wang XL and Yang L: Endoplasmic reticulum chaperone glucose-regulated protein 78 in gastric cancer: An emerging biomarker. Oncol Lett. 15:6087–6093. 2018.PubMed/NCBI | |
Shimizu A, Kaira K, Yasuda M, Asao T and Ishikawa O: Clinical and pathological significance of ER stress marker (BiP/GRP78 and PERK) expression in malignant melanoma. Pathol Oncol Res. 23:111–116. 2017. View Article : Google Scholar : PubMed/NCBI | |
Peñaranda Fajardo NM, Meijer C and Kruyt FA: The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma. Biochem Pharmacol. 118:1–8. 2016. View Article : Google Scholar : PubMed/NCBI | |
Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Yoshimastu T, Morita M and Yasumoto K: Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance. Lung Cancer. 49:55–62. 2005. View Article : Google Scholar : PubMed/NCBI | |
Scriven P, Coulson S, Haines R, Balasubramanian S, Cross S and Wyld L: Activation and clinical significance of the unfolded protein response in breast cancer. Br J Cancer. 101:1692–1698. 2009. View Article : Google Scholar : PubMed/NCBI | |
Xing X, Li Y, Liu H, Wang L and Sun L: Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis. Acta Histochem. 113:777–782. 2011. View Article : Google Scholar : PubMed/NCBI | |
Daneshmand S, Quek ML, Lin E, Lee C, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, et al: Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum Pathol. 38:1547–1552. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol. 39:1042–1049. 2007. View Article : Google Scholar | |
Langer R, Feith M, Siewert JR, Wester HJ and Hoefler H: Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus. BMC Cancer. 8:702008. View Article : Google Scholar : PubMed/NCBI | |
Nagelkerke A, Bussink J, Sweep FC and Span PN: The unfolded protein response as a target for cancer therapy. Biochim Biophys Acta. 1846:277–284. 2014.PubMed/NCBI | |
Baumeister P, Dong D, Fu Y and Lee AS: Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis. Mol Cancer Ther. 8:1086–1094. 2009. View Article : Google Scholar : PubMed/NCBI | |
Roué G, Pérez-Galán P, Mozos A, López-Guerra M, Xargay-Torrent S, Rosich L, Saborit-Villarroya I, Normant E, Campo E and Colomer D: The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP-Grp78. Blood. 117:1270–1279. 2011. View Article : Google Scholar : PubMed/NCBI | |
Al-Rawashdeh FY, Scriven P, Cameron IC, Vergani PV and Wyld L: Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 22:1099–1105. 2010. View Article : Google Scholar : PubMed/NCBI | |
Zhang L, Wang S, Wangtao, Wang Y, Wang J, Jiang L, Li S, Hu X and Wang Q: Upregulation of GRP78 and GRP94 and its function in chemotherapy resistance to VP-16 in human lung cancer cell line SK-MES-1. Cancer Invest. 27:453–458. 2009. View Article : Google Scholar : PubMed/NCBI | |
Kern J, Untergasser G, Zenzmaier C, Sarg B, Gastl G, Gunsilius E and Steurer M: GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood. 114:3960–3967. 2009. View Article : Google Scholar : PubMed/NCBI | |
Wang J, Yin Y, Hua H, Li M, Luo T, Xu L, Wang R, Liu D, Zhang Y and Jiang Y: Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med. 13((9B)): 3888–3897. 2009. View Article : Google Scholar : PubMed/NCBI | |
Morrison DK: The 14-3-3 proteins: Integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19:16–23. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lee JA, Park JE, Lee DH, Park SG, Myung PK, Park BC and Cho S: G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1. Oncogene. 27:1297–1305. 2008. View Article : Google Scholar : PubMed/NCBI | |
Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F and Chen J: 14-3-3 integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood. 110:360–369. 2007. View Article : Google Scholar : PubMed/NCBI | |
Obsilová V, Silhan J, Boura E, Teisinger J and Obsil T: 14-3-3 proteins: A family of versatile molecular regulators. Physiol Res. 57 (Suppl 3):S11–S21. 2008.PubMed/NCBI | |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H and Fu H: Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans. 30:360–365. 2002. View Article : Google Scholar : PubMed/NCBI | |
Ralhan R, Desouza LV, Matta A, Tripathi SC, Ghanny S, Datta Gupta S, Bahadur S and Siu KW: Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics. 7:1162–1173. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ralhan R, Desouza LV, Matta A, Tripathi SC, Ghanny S, Dattagupta S, Thakar A, Chauhan SS and Siu K: WiTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res. 8:300–309. 2009. View Article : Google Scholar : PubMed/NCBI | |
Arora S, Matta A, Shukla NK, Deo SV and Ralhan R: Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog. 42:97–108. 2005. View Article : Google Scholar : PubMed/NCBI | |
Sharma R, Samantaray S, Shukla NK and Ralhan R: Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics. 81:481–488. 2003. View Article : Google Scholar : PubMed/NCBI | |
Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H, Shen J, Zhao RY, Caraway NP, Katz RL, et al: Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res. 67:7901–7906. 2007. View Article : Google Scholar : PubMed/NCBI | |
Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, Lu J, Danes CG, Guo H, Lan KH, Ensor J, et al: 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res. 69:3425–3432. 2009. View Article : Google Scholar : PubMed/NCBI | |
Yang X, Cao W, Zhang L, Zhang W, Zhang X and Lin H: Targeting 14-3-3zeta in cancer therapy. Cancer Gene Ther. 19:153–159. 2012. View Article : Google Scholar : PubMed/NCBI | |
Yang X, Cao W, Zhou J, Zhang W, Zhang X, Lin W, Fei Z, Lin H and Wang B: 14-3-3ζ positive expression is associated with a poor prognosis in patients with glioblastoma. Neurosurgery. 68:932–938, discussion 938. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chatterjee D, Goldman M, Braastad CD, Darnowski J, Wyche JH, Pantazis P and Goodglick L: Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta. Int J Oncol. 25:503–509. 2004.PubMed/NCBI | |
Shen J, Person MD, Zhu J, Abbruzzese JL and Li D: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 64:9018–9026. 2004. View Article : Google Scholar : PubMed/NCBI | |
Jang JS, Cho HY, Lee YJ, Ha WS and Kim HW: The differential proteome profile of stomach cancer: Identification of the biomarker candidates. Oncol Res. 14:491–499. 2004. View Article : Google Scholar : PubMed/NCBI | |
Coelho DS and Domingos PM: Physiological roles of regulated Ire1 dependent decay. Front Genet. 5:762014. View Article : Google Scholar : PubMed/NCBI | |
Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP and Ron D: Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 287:664–666. 2000. View Article : Google Scholar : PubMed/NCBI | |
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A and Ichijo H: ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16:1345–1355. 2002. View Article : Google Scholar : PubMed/NCBI | |
Zhang L, Chen J and Fu H: Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA. 96:8511–8515. 1999. View Article : Google Scholar : PubMed/NCBI | |
Goldman EH, Chen L and Fu H: Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation. J Biol Chem. 279:10442–10449. 2004. View Article : Google Scholar : PubMed/NCBI | |
Brennan GP, Jimenez-Mateos EM, McKiernan RC, Engel T, Tzivion G and Henshall DC: Transgenic overexpression of 14-3-3 zeta protects hippocampus against endoplasmic reticulum stress and status epilepticus in vivo. PLoS One. 8:e544912013. View Article : Google Scholar : PubMed/NCBI | |
Brobey RK, Dheghani M, Foster PP, Kuro-O M and Rosenblatt KP: Klotho regulates 14-3-3ζ monomerization and binding to the ASK1 signaling complex in response to oxidative stress. PLoS One. 10:e01419682015. View Article : Google Scholar : PubMed/NCBI | |
Yde CW and Issinger OG: Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. Int J Oncol. 29:1397–1404. 2006.PubMed/NCBI | |
Lauritzen G, Jensen MB, Boedtkjer E, Dybboe R, Aalkjaer C, Nylandsted J and Pedersen SF: Cisplatin-induced cell death in MCF-7 breast cancer cells: Roles of ΔNErbB2 and pH regulatory ion transporters NHE1 and NBCn1. Exp Cell Res. 316:2538–2553. 2010. View Article : Google Scholar : PubMed/NCBI | |
Jiang Y, Ji F, Liu Y, He M, Zhang Z, Yang J, Wang N, Zhong C, Jin Q, Ye X, et al: Cisplatin-induced autophagy protects breast cancer cells from apoptosis by regulating yes-associated protein. Oncol Rep. 38:3668–3676. 2017.PubMed/NCBI | |
Al-Taweel N, Varghese E, Florea AM and Büsselberg D: Cisplatin (CDDP) triggers cell death of MCF-7 cells following disruption of intracellular calcium ([Ca(2+)]i) homeostasis. J Toxicol Sci. 39:765–774. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lee AS: GRP78 induction in cancer: Therapeutic and prognostic implications. Cancer Res. 67:3496–3499. 2007. View Article : Google Scholar : PubMed/NCBI | |
Wang M, Wey S, Zhang Y, Ye R and Lee AS: Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal. 11:2307–2316. 2009. View Article : Google Scholar : PubMed/NCBI | |
Li J, Ni M, Lee B, Barron E, Hinton DR and Lee AS: The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ. 15:1460–1471. 2008. View Article : Google Scholar : PubMed/NCBI | |
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI | |
Pfaffl MW, Horgan GW and Dempfle L: Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e362002. View Article : Google Scholar : PubMed/NCBI | |
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47(D1): D607–D613. 2019. View Article : Google Scholar : PubMed/NCBI | |
Bruno S and Darzynkiewicz Z: Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif. 25:31–40. 1992. View Article : Google Scholar : PubMed/NCBI | |
He Y, Liu Z, Qiao C, Xu M, Yu J and Li G: Expression and significance of Wnt signaling components and their target genes in breast carcinoma. Mol Med Rep. 9:137–143. 2014. View Article : Google Scholar : PubMed/NCBI | |
Sherr CJ: Cancer cell cycles. Science. 274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI | |
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature. 366:701–704. 1993. View Article : Google Scholar : PubMed/NCBI | |
Lukyanova NY, Rusetskya NV, Tregubova NA and Chekhun VF: Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin. Exp Oncol. 31:87–91. 2009.PubMed/NCBI | |
Salvesen GS and Abrams JM: Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene. 23:2774–2784. 2004. View Article : Google Scholar : PubMed/NCBI | |
Castri P, Lee YJ, Ponzio T, Maric D, Spatz M, Bembry J and Hallenbeck J: Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling. Biochim Biophys Acta. 1843:640–651. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lin JF, Lin YC, Tsai TF, Chen HE, Chou KY and Hwang TIS: Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells. Drug Des Devel Ther. 2017.1517-1533.2017. View Article : Google Scholar | |
Pozuelo-Rubio M: Regulation of autophagic activity by 14-3-3ζ proteins associated with class III phosphatidylinositol-3-kinase. Cell Death Differ. 18:479–492. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lee AS: The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci. 26:504–10. 2001. View Article : Google Scholar : PubMed/NCBI | |
Hendershot LM: The ER function BiP is a master regulator of ER function. Mt Sinai J Med. 71:289–297. 2004.PubMed/NCBI | |
Ye X, Zhou Xu and Zhang H: Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune/autoinflammatory. Front Immunol. 9:2332018. View Article : Google Scholar : PubMed/NCBI | |
Zhu Y, Zhao L, Liu L, Gao P, Tian W, Wang X, Jin H, Xu H and Chen Q: Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell. 1:468–477. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lee AS, Brandhorst S, Rangel DF, Navarrete G, Cohen P, Longo VD, Chen J, Groshen S, Morgan TE and Dubeau L: Effects of prolonged GRP78 haploinsufficiency on organ homeostasis, behavior, cancer and chemo-toxic resistance in aged mice. Sci Rep. 7:409192017. View Article : Google Scholar : PubMed/NCBI | |
Suh DH, Kim MK, Kim HS, Chung HH and Song YS: Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Ann N Y Acad Sci. 1271:20–32. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tallóczy Z, Jiang W, Virgin HW IV, Leib DA, Scheuner D, Kaufman RJ, Eskelinen EL and Levine B: Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway. Proc Natl Acad Sci USA. 99:190–195. 2002. View Article : Google Scholar : PubMed/NCBI | |
Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E and Momoi T: ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 14:230–239. 2007. View Article : Google Scholar : PubMed/NCBI | |
Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, Yoshinaga K, et al: Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol. 26:9220–9231. 2006. View Article : Google Scholar : PubMed/NCBI | |
Funderburk SF, Wang QJ and Yue Z: The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. Trends Cell Biol. 20:355–362. 2010. View Article : Google Scholar : PubMed/NCBI | |
Zhang L, Wang H, Ding K and Xu J: FTY720 induces autophagy related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 236:432015. View Article : Google Scholar : PubMed/NCBI | |
Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, Roelandt R, De Rycke R, Verspurten J, Declercq W, et al: Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 1:e182010. View Article : Google Scholar : PubMed/NCBI | |
Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, et al: Cyclin D1 governs adhesion and motility of macrophages. Mol Biol Cell. 14:2005–2015. 2003. View Article : Google Scholar : PubMed/NCBI | |
Holnthoner W, Pillinger M, Groger M, Wolff K, Ashton AW, Albanese C, Neumeister P, Pestell RG and Petzelbauer P: Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem. 277:45847–45853. 2002. View Article : Google Scholar : PubMed/NCBI | |
Barrios CH, Sampaio C, Vinholes J and Caponero R: What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? Ann Oncol. 20:1157–1162. 2009. View Article : Google Scholar : PubMed/NCBI | |
Alqahtani A, Ayesh HSK and Halawani H: PIK3CA gene mutations in solid malignancies: Association with clinicopathological parameters and prognosis. Cancers (Basel). 12:932019. View Article : Google Scholar |